Compare PAGS & VCYT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PAGS | VCYT |
|---|---|---|
| Founded | 2006 | 2006 |
| Country | Brazil | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Medical Specialities |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9B | 3.0B |
| IPO Year | N/A | 2013 |
| Metric | PAGS | VCYT |
|---|---|---|
| Price | $11.42 | $36.73 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 8 |
| Target Price | $11.86 | ★ $46.00 |
| AVG Volume (30 Days) | ★ 4.1M | 871.5K |
| Earning Date | 03-05-2026 | 02-25-2026 |
| Dividend Yield | ★ 1.27% | N/A |
| EPS Growth | ★ 16.68 | N/A |
| EPS | ★ 1.37 | 0.38 |
| Revenue | ★ $3,662,823,389.00 | $495,141,000.00 |
| Revenue This Year | $14.75 | $16.72 |
| Revenue Next Year | $5.68 | $11.31 |
| P/E Ratio | ★ $8.03 | $95.13 |
| Revenue Growth | 10.88 | ★ 16.41 |
| 52 Week Low | $6.70 | $22.61 |
| 52 Week High | $12.32 | $50.71 |
| Indicator | PAGS | VCYT |
|---|---|---|
| Relative Strength Index (RSI) | 59.26 | 37.76 |
| Support Level | $10.53 | $34.71 |
| Resistance Level | $11.90 | $38.98 |
| Average True Range (ATR) | 0.51 | 1.80 |
| MACD | -0.04 | -0.43 |
| Stochastic Oscillator | 58.31 | 19.56 |
PagSeguro Digital Ltd is a Brazilian-based company that acts as a provider of financial technology solutions focused on Micro-Merchants, Small Companies and Medium-Sized Companies (SMEs), in Brazil. The company provides a range of solutions and tools such as cash-in and cash-out options and provides access to working capital to help to manage its cash flow. It delivers an end-to-end digital ecosystem to address day-to-day financial needs, including receiving and spending funds and managing and growing businesses for clients. The company also offers the Free PagSeguro Digital Account delivering Cash-In Solutions, Online and In-Person Payment Tools, Online Payment Tools; and Web Check Outs offer tokenization, handling of shipping information, and others.
Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder). In addition, its Percepta Nasal Swab test is being run in CLIA labs in support of clinical studies.